Sierra Oncology, Inc. EPS - Earnings per Share 2015-2022 | SRRA
Sierra Oncology, Inc. eps - earnings per share from 2015 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Sierra Oncology, Inc. Annual EPS |
| 2021 |
$-7.14 |
| 2020 |
$-7.70 |
| 2019 |
$-30.30 |
| 2018 |
$-30.16 |
| 2017 |
$-33.60 |
| 2016 |
$-63.20 |
| 2015 |
$-1,258.80 |
| 2014 |
$-2,763.20 |
| 2013 |
$-767.20 |
| Sierra Oncology, Inc. Quarterly EPS |
| 2022-03-31 |
$-1.33 |
| 2021-12-31 |
$-1.66 |
| 2021-09-30 |
$-2.10 |
| 2021-06-30 |
$-1.67 |
| 2021-03-31 |
$-1.71 |
| 2020-12-31 |
$-1.59 |
| 2020-09-30 |
$-1.39 |
| 2020-06-30 |
$-1.58 |
| 2020-03-31 |
$-3.14 |
| 2019-12-31 |
$-8.42 |
| 2019-09-30 |
$-6.91 |
| 2019-06-30 |
$-7.97 |
| 2019-03-31 |
$-7.00 |
| 2018-12-31 |
$-7.76 |
| 2018-09-30 |
$-8.40 |
| 2018-06-30 |
$-6.40 |
| 2018-03-31 |
$-7.60 |
| 2017-12-31 |
$-7.60 |
| 2017-09-30 |
$-7.60 |
| 2017-06-30 |
$-8.00 |
| 2017-03-31 |
$-10.40 |
| 2016-12-31 |
$-12.00 |
| 2016-09-30 |
$-20.00 |
| 2016-06-30 |
$-17.20 |
| 2016-03-31 |
$-14.00 |
| 2015-12-31 |
$3,859.60 |
| 2015-09-30 |
$-441.20 |
| 2015-06-30 |
$-4,164.00 |
| 2015-03-31 |
$-513.20 |
| 2014-12-31 |
$44.00 |
| 2014-09-30 |
$-374.80 |
| 2014-06-30 |
$-2,201.60 |
| 2014-03-31 |
$-230.80 |
